edited by Juan Alvarez and Brian Shoichet
Features:
Virtual Screening in Drug Discovery does not overwhelm you with more information than you need. Many of the strategies outlined will transcend the specifics of any given method.
Virtual Screening in Drug Discovery does not proclaim to offer single best ways to use the programs. What it does is provide a snapshot of virtual screening that gives you easy access to strategies and techniques for lead discovery.
Part I offers perspectives on both ligand-based and docking-based virtual screens. The authors of these chapters frame many of the challenges currently facing the field. Part II considers the choice of compounds that are best suited as drug leads. Part III discusses ligand-based approaches, including descriptor-based similarity, traditional pharmacophore searching, and similarity based 3D-pharmacophore fingerprints. The final two sections are devoted to molecular docking. Part IV outlines some important and practical considerations relating to the energetics of protein-ligand binding and target-site topography, whereas specific docking algorithms and strategies are discussed in Part V.
Contents
Perspectives on Virtual Screening
Compound and Hit Suitability for Virtual Screening
Ligand-based Virtual Screening Approaches
Important Considerations Impacting Molecular Docking
Docking Strategies and Algorithms
Index
![]()
|